Adrenoleukodystrophy Drugs Market - Global Outlook and Forecast 2021-2027

Code: RW00014517673
Market Monitor Global
Sep-2021
Life Sciences
91 Pages

This report contains market size and forecasts of Adrenoleukodystrophy Drugs in global, including the following market information:
Global Adrenoleukodystrophy Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Adrenoleukodystrophy Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Adrenoleukodystrophy Drugs companies in 2020 (%)
The global Adrenoleukodystrophy Drugs market was valued at 299.9 million in 2020 and is projected to reach US$ 528.6 million by 2027, at a CAGR of 15.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Adrenoleukodystrophy Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adrenoleukodystrophy Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Adrenoleukodystrophy Drugs Market Segment Percentages, By Type, 2020 (%)
Hormone Replacement
Transplant
Others

Global Adrenoleukodystrophy Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Adrenoleukodystrophy Drugs Market Segment Percentages, By Application, 2020 (%)
Childhood Cerebral ALD
Adrenomyeloneuropathy (AMN)
Addison-only
Others

Global Adrenoleukodystrophy Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Adrenoleukodystrophy Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adrenoleukodystrophy Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Adrenoleukodystrophy Drugs revenues share in global market, 2020 (%)
Key companies Adrenoleukodystrophy Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Adrenoleukodystrophy Drugs sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bluebird Bio Inc
NeuroVia, Inc.
Orpheris, Inc.
Minoryx
MedDay Pharmaceuticals

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Adrenoleukodystrophy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adrenoleukodystrophy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adrenoleukodystrophy Drugs Overall Market Size
2.1 Global Adrenoleukodystrophy Drugs Market Size: 2021 VS 2027
2.2 Global Adrenoleukodystrophy Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Adrenoleukodystrophy Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Adrenoleukodystrophy Drugs Players in Global Market
3.2 Top Global Adrenoleukodystrophy Drugs Companies Ranked by Revenue
3.3 Global Adrenoleukodystrophy Drugs Revenue by Companies
3.4 Global Adrenoleukodystrophy Drugs Sales by Companies
3.5 Global Adrenoleukodystrophy Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Adrenoleukodystrophy Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Adrenoleukodystrophy Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Players in Global Market
3.8.1 List of Global Tier 1 Adrenoleukodystrophy Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Adrenoleukodystrophy Drugs Market Size Markets, 2021 & 2027
4.1.2 Hormone Replacement
4.1.3 Transplant
4.1.4 Others
4.2 By Type - Global Adrenoleukodystrophy Drugs Revenue & Forecasts
4.2.1 By Type - Global Adrenoleukodystrophy Drugs Revenue, 2016-2021
4.2.2 By Type - Global Adrenoleukodystrophy Drugs Revenue, 2022-2027
4.2.3 By Type - Global Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Adrenoleukodystrophy Drugs Sales & Forecasts
4.3.1 By Type - Global Adrenoleukodystrophy Drugs Sales, 2016-2021
4.3.2 By Type - Global Adrenoleukodystrophy Drugs Sales, 2022-2027
4.3.3 By Type - Global Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adrenoleukodystrophy Drugs Market Size, 2021 & 2027
5.1.2 Childhood Cerebral ALD
5.1.3 Adrenomyeloneuropathy (AMN)
5.1.4 Addison-only
5.1.5 Others
5.2 By Application - Global Adrenoleukodystrophy Drugs Revenue & Forecasts
5.2.1 By Application - Global Adrenoleukodystrophy Drugs Revenue, 2016-2021
5.2.2 By Application - Global Adrenoleukodystrophy Drugs Revenue, 2022-2027
5.2.3 By Application - Global Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Adrenoleukodystrophy Drugs Sales & Forecasts
5.3.1 By Application - Global Adrenoleukodystrophy Drugs Sales, 2016-2021
5.3.2 By Application - Global Adrenoleukodystrophy Drugs Sales, 2022-2027
5.3.3 By Application - Global Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Adrenoleukodystrophy Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Adrenoleukodystrophy Drugs Market Size, 2021 & 2027
6.2 By Region - Global Adrenoleukodystrophy Drugs Revenue & Forecasts
6.2.1 By Region - Global Adrenoleukodystrophy Drugs Revenue, 2016-2021
6.2.2 By Region - Global Adrenoleukodystrophy Drugs Revenue, 2022-2027
6.2.3 By Region - Global Adrenoleukodystrophy Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Adrenoleukodystrophy Drugs Sales & Forecasts
6.3.1 By Region - Global Adrenoleukodystrophy Drugs Sales, 2016-2021
6.3.2 By Region - Global Adrenoleukodystrophy Drugs Sales, 2022-2027
6.3.3 By Region - Global Adrenoleukodystrophy Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Adrenoleukodystrophy Drugs Revenue, 2016-2027
6.4.2 By Country - North America Adrenoleukodystrophy Drugs Sales, 2016-2027
6.4.3 US Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.4.4 Canada Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.4.5 Mexico Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Adrenoleukodystrophy Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Adrenoleukodystrophy Drugs Sales, 2016-2027
6.5.3 Germany Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.4 France Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.5 U.K. Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.6 Italy Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.7 Russia Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.5.9 Benelux Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Adrenoleukodystrophy Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Adrenoleukodystrophy Drugs Sales, 2016-2027
6.6.3 China Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.6.4 Japan Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.6.5 South Korea Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.6.7 India Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Adrenoleukodystrophy Drugs Revenue, 2016-2027
6.7.2 By Country - South America Adrenoleukodystrophy Drugs Sales, 2016-2027
6.7.3 Brazil Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.7.4 Argentina Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Adrenoleukodystrophy Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Adrenoleukodystrophy Drugs Sales, 2016-2027
6.8.3 Turkey Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.8.4 Israel Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Adrenoleukodystrophy Drugs Market Size, 2016-2027
6.8.6 UAE Adrenoleukodystrophy Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bluebird Bio Inc
7.1.1 Bluebird Bio Inc Corporate Summary
7.1.2 Bluebird Bio Inc Business Overview
7.1.3 Bluebird Bio Inc Adrenoleukodystrophy Drugs Major Product Offerings
7.1.4 Bluebird Bio Inc Adrenoleukodystrophy Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Bluebird Bio Inc Key News
7.2 NeuroVia, Inc.
7.2.1 NeuroVia, Inc. Corporate Summary
7.2.2 NeuroVia, Inc. Business Overview
7.2.3 NeuroVia, Inc. Adrenoleukodystrophy Drugs Major Product Offerings
7.2.4 NeuroVia, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in Global (2016-2021)
7.2.5 NeuroVia, Inc. Key News
7.3 Orpheris, Inc.
7.3.1 Orpheris, Inc. Corporate Summary
7.3.2 Orpheris, Inc. Business Overview
7.3.3 Orpheris, Inc. Adrenoleukodystrophy Drugs Major Product Offerings
7.3.4 Orpheris, Inc. Adrenoleukodystrophy Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Orpheris, Inc. Key News
7.4 Minoryx
7.4.1 Minoryx Corporate Summary
7.4.2 Minoryx Business Overview
7.4.3 Minoryx Adrenoleukodystrophy Drugs Major Product Offerings
7.4.4 Minoryx Adrenoleukodystrophy Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Minoryx Key News
7.5 MedDay Pharmaceuticals
7.5.1 MedDay Pharmaceuticals Corporate Summary
7.5.2 MedDay Pharmaceuticals Business Overview
7.5.3 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Major Product Offerings
7.5.4 MedDay Pharmaceuticals Adrenoleukodystrophy Drugs Sales and Revenue in Global (2016-2021)
7.5.5 MedDay Pharmaceuticals Key News
8 Global Adrenoleukodystrophy Drugs Production Capacity, Analysis
8.1 Global Adrenoleukodystrophy Drugs Production Capacity, 2016-2027
8.2 Adrenoleukodystrophy Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Adrenoleukodystrophy Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Adrenoleukodystrophy Drugs Supply Chain Analysis
10.1 Adrenoleukodystrophy Drugs Industry Value Chain
10.2 Adrenoleukodystrophy Drugs Upstream Market
10.3 Adrenoleukodystrophy Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Adrenoleukodystrophy Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Adrenoleukodystrophy Drugs in Global Market
Table 2. Top Adrenoleukodystrophy Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Adrenoleukodystrophy Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Adrenoleukodystrophy Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Adrenoleukodystrophy Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Adrenoleukodystrophy Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Adrenoleukodystrophy Drugs Price (2016-2021) & (US$/Unit)
Table 8. Global Manufacturers Adrenoleukodystrophy Drugs Product Type
Table 9. List of Global Tier 1 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adrenoleukodystrophy Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE